These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27322108)

  • 1. Viral inhibitors of NKG2D ligands for tumor surveillance.
    Chávez-Blanco A; Chacón-Salinas R; Dominguez-Gomez G; Gonzalez-Fierro A; Perez-Cardenas E; Taja-Chayeb L; Trejo-Becerril C; Duenas-Gonzalez A
    Expert Opin Ther Targets; 2016 Nov; 20(11):1375-1387. PubMed ID: 27322108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral Evasion of Natural Killer Cell Activation.
    Ma Y; Li X; Kuang E
    Viruses; 2016 Apr; 8(4):95. PubMed ID: 27077876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKG2D and its ligands.
    Obeidy P; Sharland AF
    Int J Biochem Cell Biol; 2009 Dec; 41(12):2364-7. PubMed ID: 19631280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural killer group 2D receptor and its ligands in cancer immune escape.
    Duan S; Guo W; Xu Z; He Y; Liang C; Mo Y; Wang Y; Xiong F; Guo C; Li Y; Li X; Li G; Zeng Z; Xiong W; Wang F
    Mol Cancer; 2019 Feb; 18(1):29. PubMed ID: 30813924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lectin populations of NK cells against tumors coupled to viral infections (review of literature).].
    Lakhtin VM; Lakhtin MV; Mironov AY; Aleshkin VA; Аfanasiev SS
    Klin Lab Diagn; 2019; 64(5):314-320. PubMed ID: 31185156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of NKG2D Expression and Signaling by Endocytosis.
    Molfetta R; Quatrini L; Zitti B; Capuano C; Galandrini R; Santoni A; Paolini R
    Trends Immunol; 2016 Nov; 37(11):790-802. PubMed ID: 27667711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance of NKG2D and its inhibitory counterparts: how does tumor escape from innate immunity?
    Zhang C; Zhang J; Wei H; Tian Z
    Int Immunopharmacol; 2005 Jul; 5(7-8):1099-111. PubMed ID: 15914316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ras activation induces expression of Raet1 family NK receptor ligands.
    Liu XV; Ho SS; Tan JJ; Kamran N; Gasser S
    J Immunol; 2012 Aug; 189(4):1826-34. PubMed ID: 22798674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor immunity. A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection.
    Deng W; Gowen BG; Zhang L; Wang L; Lau S; Iannello A; Xu J; Rovis TL; Xiong N; Raulet DH
    Science; 2015 Apr; 348(6230):136-9. PubMed ID: 25745066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Innate immune recognition of double-stranded RNA triggers increased expression of NKG2D ligands after virus infection.
    Esteso G; Guerra S; Valés-Gómez M; Reyburn HT
    J Biol Chem; 2017 Dec; 292(50):20472-20480. PubMed ID: 28986447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications.
    Siemaszko J; Marzec-Przyszlak A; Bogunia-Kubik K
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer immunotherapy using NKG2D and DNAM-1 systems.
    Morisaki T; Onishi H; Katano M
    Anticancer Res; 2012 Jun; 32(6):2241-7. PubMed ID: 22641658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leveraging NKG2D Ligands in Immuno-Oncology.
    Fuertes MB; Domaica CI; Zwirner NW
    Front Immunol; 2021; 12():713158. PubMed ID: 34394116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.
    Campbell TM; McSharry BP; Steain M; Slobedman B; Abendroth A
    J Virol; 2015 Aug; 89(15):7932-43. PubMed ID: 25995251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Release of Soluble Ligands for the Activating NKG2D Receptor: One More Immune Evasion Strategy Evolved by HIV-1 ?
    Giuliani E; Vassena L; Cerboni C; Doria M
    Curr Drug Targets; 2016; 17(1):54-64. PubMed ID: 26122035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of immune cell function and differentiation by the NKG2D receptor.
    Zafirova B; Wensveen FM; Gulin M; Polić B
    Cell Mol Life Sci; 2011 Nov; 68(21):3519-29. PubMed ID: 21898152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of NKG2D-Dependent NK Cell Functions: The Yin and the Yang of Receptor Endocytosis.
    Molfetta R; Quatrini L; Santoni A; Paolini R
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28767057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP expression on human NK cells contributes to HBV persistence.
    Sun C; Fu B; Gao Y; Liao X; Sun R; Tian Z; Wei H
    PLoS Pathog; 2012; 8(3):e1002594. PubMed ID: 22438812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The NKG2D receptor: immunobiology and clinical implications.
    Burgess SJ; Maasho K; Masilamani M; Narayanan S; Borrego F; Coligan JE
    Immunol Res; 2008; 40(1):18-34. PubMed ID: 18193361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKG2D signaling in cancer immunosurveillance.
    López-Soto A; Huergo-Zapico L; Acebes-Huerta A; Villa-Alvarez M; Gonzalez S
    Int J Cancer; 2015 Apr; 136(8):1741-50. PubMed ID: 24615398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.